Bionano Genomics, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bionano Genomics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Bionano Genomics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$43.9M, a 61.2% increase year-over-year.
  • Bionano Genomics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$117M, a 48.6% increase year-over-year.
  • Bionano Genomics, Inc. annual Operating Income (Loss) for 2023 was -$215M, a 63.4% decline from 2022.
  • Bionano Genomics, Inc. annual Operating Income (Loss) for 2022 was -$132M, a 70.8% decline from 2021.
  • Bionano Genomics, Inc. annual Operating Income (Loss) for 2021 was -$77.1M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$215M -$83.5M -63.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$132M -$54.6M -70.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$77.1M -$38.6M -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$38.6M -$12.7M -49% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$25.9M -$5.46M -26.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 -$20.4M +$2.8M +12.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$23.2M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.